As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Alexza will likely underperform.
Mark CPA CFO, Principal Accounting Officer, Sr. VP of Fin. and Secretary
Alexza Price and Market Media
The median price of Alexza for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 4.38 with a coefficient of variation of 6.09. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 4.51, and mean deviation of 0.22. The Stock received substential amount of media coverage during this period.
Alexza Pharmaceuticals Inc [ALXA] is traded on NASDAQ General Markets in USA. It is located in Mountain View, CA and employs 63 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 83.78 M. Alexza Pharmaceuticals Inc conducts business under Healthcare sector and is part of Drug Manufacturers - Other industry. This company has 15.78 M outstanding shares of which 3.05 M shares are presently shorted by private and institutional investors with about 17.0 trading days to cover.
Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of novel proprietary solutions for the acute treatment of central nervous system conditions worldwide. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.83%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
